000			01795 a2200493 4500
005			20250511194038.0
264		0	_c19920720
008			199207s 0 0 eng d
022			_a0735-1097
024	7		_a10.1016/0735-1097(92)90132-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aGoldhaber, S Z
245	0	0	_aRecombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. _h[electronic resource]
260			_bJournal of the American College of Cardiology _cJul 1992
300			_a24-30 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCause of Death
650	0	4	_aConfidence Intervals
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPulmonary Embolism _xblood
650	0	4	_aRadiography
650	0	4	_aRecombinant Proteins _xtherapeutic use
650	0	4	_aThrombolytic Therapy _xadverse effects
650	0	4	_aTissue Plasminogen Activator _xtherapeutic use
650	0	4	_aUrokinase-Type Plasminogen Activator _xtherapeutic use
700	1		_aKessler, C M
700	1		_aHeit, J A
700	1		_aElliott, C G
700	1		_aFriedenberg, W R
700	1		_aHeiselman, D E
700	1		_aWilson, D B
700	1		_aParker, J A
700	1		_aBennett, D
700	1		_aFeldstein, M L
773	0		_tJournal of the American College of Cardiology _gvol. 20 _gno. 1 _gp. 24-30
856	4	0	_uhttps://doi.org/10.1016/0735-1097(92)90132-7 _zAvailable from publisher's website
999			_c1614009 _d1614009